0.54
-0.0919(-14.45%)
Currency In USD
| Previous Close | 0.64 |
| Open | 0.52 |
| Day High | 0.57 |
| Day Low | 0.42 |
| 52-Week High | 2.52 |
| 52-Week Low | 0.21 |
| Volume | 9.65M |
| Average Volume | 15.67M |
| Market Cap | 20.58M |
| PE | -0.54 |
| EPS | -1.01 |
| Moving Average 50 Days | 0.44 |
| Moving Average 200 Days | 0.67 |
| Change | -0.09 |
If you invested $1000 in HCW Biologics Inc. (HCWB) since IPO date, it would be worth $86.35 as of February 05, 2025 at a share price of $0.544. Whereas If you bought $1000 worth of HCW Biologics Inc. (HCWB) shares 3 years ago, it would be worth $240.71 as of February 05, 2025 at a share price of $0.544.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
HCW Biologics Granted FDA Clearance to Evaluate One of the Company’s Lead Product Candidates in a First-In-Human Phase 1 Clinical Trial
GlobeNewswire Inc.
Feb 03, 2025 12:15 PM GMT
This study will evaluate HCW9302 in patients with moderate to severe alopecia areataMIRAMAR, Fla., Feb. 03, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (“HCWB” or the “Company”) (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company
HCW Biologics’ Founder and CEO to Address Opportunities and Challenges in Biomanufacturing for Cell and Gene Therapies During J.P. Morgan Week in San Francisco on January 15, 2025
GlobeNewswire Inc.
Jan 15, 2025 12:00 PM GMT
Invited Speaker at 2025 GenScript Biotech Global ForumMIRAMAR, Fla., Jan. 15, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (“HCWB” or “HCW Biologics”), (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and
HCW Biologics Inc. Received NASDAQ Staff Determination Letter
GlobeNewswire Inc.
Dec 23, 2024 1:10 PM GMT
Company Expected Notice for Continued Deficiency and Delist Letter from the Nasdaq Stock Market Company Intends to Request Hearing to Appeal in a Timely Manner MIRAMAR, Fla., Dec. 23, 2024 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “H